News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Anthropic priced its IPO at $83 per Class A share.
  • The Anthropic offering totals 980,000,000 shares, mostly sold by the company.
  • Anthropic will list on Nasdaq under ticker ANT on Nov 19, 2026, with closing expected Nov 20.
  • Tilly's has about $52 million net cash and trades near 7.6x EV/EBITDA.
  • Analyst projects TLYS could reach $6 within 180 trading days citing margin improvements.

Latest Articles

MindWave Innovations Inc., a Wholly Owned Subsidiary of Apimeds Pharmaceuticals US, Inc., Announces MindChain: World's First Fully Insured Blockchain, Launching in October

MindWave Innovations Inc., a Wholly Owned Subsidiary of Apimeds Pharmaceuticals US, Inc., Announces MindChain: World's First Fully Insured Blockchain, Launching in October

MindWave Innovations Inc., a subsidiary of Apimeds Pharmaceuticals (NYSE American: APUS), announced MindChain, the first fully insured, production-grade Ethereum-compatible Layer 2 blockchain, launching in October 2026. The NILA token will become the native asset of this blockchain and will be available for U.S. trading on the licensed Webot exchan…

SEGG Media Amends Lawsuit Against White Diamond Research and Increases Damages Sought to $35 Million

SEGG Media Amends Lawsuit Against White Diamond Research and Increases Damages Sought to $35 Million

Sports Entertainment Gaming Global Corporation (SEGG Media) has amended its lawsuit against White Diamond Research LLC and Adam Gefvert, increasing the damages sought from $20 million to $35 million. The company alleges that false and disparaging statements by the defendants triggered a continued decline in SEGG's stock price, harming shareholder v…

BofA Says a July Fed Rate Hike Would Break with Decades of Practice

BofA Says a July Fed Rate Hike Would Break with Decades of Practice

Bank of America expects the Federal Reserve to keep policy rates unchanged at its July meeting, warning that a surprise uptick would violate long-standing market norms. Analyst Mark Cabana identified a hold as the base case with two dissents, and the bank points to futures pricing, oil-driven inflation risk, and the statistical record since 1994 to…

Gaxos Sharpens Focus to Accelerate Growth Across Revenue-Generating AI and Health and Wellness Platforms

Gaxos Sharpens Focus to Accelerate Growth Across Revenue-Generating AI and Health and Wellness Platforms

Gaxos.ai Inc. announced the sale of its gaming assets to concentrate on its revenue-generating AI applications and personalized health and wellness products. The company reported a significant increase in Q1 2026 revenue to $1.81 million, driven largely by RNK Health and Gaxos Labs subscriptions. The strategic realignment aims to enhance customer a…

Nexentis Technologies Subsidiary MitoCareX Bio Selects Transport Protein Candidate for Drug Discovery Campaign

Nexentis Technologies Subsidiary MitoCareX Bio Selects Transport Protein Candidate for Drug Discovery Campaign

Nexentis Technologies' wholly owned subsidiary, MitoCareX Bio Ltd., has completed its internal prioritization process and selected a candidate SLC transport protein for an upcoming drug discovery campaign. This decision follows broad structural analysis enabled by the proprietary MITOLINE® algorithm, reflecting tangible progress in Nexentis' drug d…

Noble Shares Drop After Q2 Miss, Guidance Cut and Rig Suspensions

Noble Shares Drop After Q2 Miss, Guidance Cut and Rig Suspensions

Noble Corp reported a weak second quarter with an adjusted EPS of $0.01 versus the $0.19 analyst consensus, a $37 million net loss, and a downward revision to full-year revenue guidance. Operational suspensions of two Brazil rigs and the end of a Black Sea contract were cited as key drivers of the revenue decline and negative free cash flow, prompt…

FactSet expands partnership with RepRisk to strengthen sustainable investing solutions suite for clients

FactSet expands partnership with RepRisk to strengthen sustainable investing solutions suite for clients

FactSet has expanded its partnership with RepRisk to integrate RepRisk's business conduct risk intelligence solutions into its sustainable investing suite. This collaboration provides FactSet clients with enhanced risk data and analytics across investment workflows to better identify, monitor, and manage business conduct risks and support more info…

Safe Pro Group to Host SPAI Innovation Day Featuring Live AI Powered Drone Field Operations on August 25, 2026

Safe Pro Group to Host SPAI Innovation Day Featuring Live AI Powered Drone Field Operations on August 25, 2026

Safe Pro Group Inc., a Nasdaq-listed AI-enabled security and defense technology company, announced it will hold an Innovation Day on August 25, 2026, in Aventura, Florida. The event will demonstrate live drone operations using their AI-powered threat detection technology, including the patented SPOTD system and NODE edge compute solution. The compa…

VeriSign Upgrade: Buy the Dip Into Durable DNS Cash Flow

VeriSign Upgrade: Buy the Dip Into Durable DNS Cash Flow

VeriSign's domain-registry monopoly and heavy free cash flow profile justify a renewed buy thesis after recent weakness. The stock has pulled back into technical support while fundamentals - $1.07B in FCF, near-$25B market cap, and expanding buyback activity - underwrite upside. We lay out an entry at $274.81, a $252 stop and a $310 target over a 4…

Pluri Advances Commercial Expansion Through Its Subsidiary Cellav, Completing Regulatory Registration in the UK

Pluri Advances Commercial Expansion Through Its Subsidiary Cellav, Completing Regulatory Registration in the UK

Pluri Inc., through its subsidiary Cellav Health and Aesthetics Ltd., has completed cosmetic regulatory registration for its regenerative aesthetics product, Regenativo+, in the UK. This milestone allows commercial launch in the UK market, estimated at $900 million annually, and supports the company's broader strategy to expand globally in regenera…

Enlivex Announces $400,000,000 Private Placement

Enlivex Announces $400,000,000 Private Placement

Enlivex Ltd. (Nasdaq: ENLV) has entered into a private placement agreement with a single institutional investor to raise approximately $400 million through the sale of ordinary shares at a premium to the current trading price. The investor has elected to fund using RAIN tokens, linked to decentralized prediction markets in which Enlivex also invest…

Standard BioTools Announces Sale of Mass Cytometry Business and Illumina’s Buyout of Contingent Payments to Advance Merger with Treeline Biosciences

Standard BioTools Announces Sale of Mass Cytometry Business and Illumina’s Buyout of Contingent Payments to Advance Merger with Treeline Biosciences

Standard BioTools announced the sale of its Mass Cytometry business to Multiplex Bio, a $30 million buyout of contingent payments related to Illumina's acquisition of its SomaLogic business, and early FTC approval advancing its merger with Treeline Biosciences. The Mass Cytometry sale ensures product continuity and ongoing investment while enabling…

Pacira BioSciences Announces New National Survey Revealing the Hidden Toll of Pain on America’s Workforce

Pacira BioSciences Announces New National Survey Revealing the Hidden Toll of Pain on America’s Workforce

Pacira BioSciences released a national survey revealing significant impacts of orthopedic pain, especially knee pain, on physically active US workers. The survey underscores the high prevalence of pain affecting income, career opportunities, and quality of life, with a strong interest in long-lasting, non-opioid pain treatments. The findings emphas…

Franklin Electric Reports Second Quarter 2026 Results

Franklin Electric Reports Second Quarter 2026 Results

Franklin Electric reported second quarter 2026 net sales of $622.9 million, up 6% year-over-year, driven by gains across Water Systems, Energy Systems, and Distribution segments. Adjusted diluted EPS rose 18% to $1.55. The company raised its full year 2026 revenue and EPS guidance, citing organic growth initiatives, acquisitions, and solid demand i…

Kratos Completes Construction of $50 Million State-of-the-Art Hypersonic Systems Payload Integration Facility in Indiana Ahead of Schedule

Kratos Completes Construction of $50 Million State-of-the-Art Hypersonic Systems Payload Integration Facility in Indiana Ahead of Schedule

Kratos Defense & Security Solutions has completed construction of its $50 million Indiana Payload Integration Facility (IPIF) ahead of schedule. The 68,000-square-foot facility is designed for advanced manufacturing, integration, and testing of experimental hypersonic payloads to accelerate hypersonic technology development and flight testing. This…

Oxford Lane Capital Corp. Announces Net Asset Value and Selected Financial Results for the First Fiscal Quarter, and Declaration of Common Stock Distributions for the Months Ending October, November, and December 2026

Oxford Lane Capital Corp. Announces Net Asset Value and Selected Financial Results for the First Fiscal Quarter, and Declaration of Common Stock Distributions for the Months Ending October, November, and December 2026

Oxford Lane Capital Corp. announced its first fiscal quarter 2026 financial results, including a net asset value per share increase to $10.74 and declared monthly common stock distributions of $0.20 per share for October through December 2026. The company reported net investment income of $50.2 million and core net investment income of $93.4 millio…

Corbus Pharmaceuticals Announces FDA Clearance to Initiate TEMPO-1 Registrational Study of CRB-701 in Patients with 2L Oropharyngeal Cancer

Corbus Pharmaceuticals Announces FDA Clearance to Initiate TEMPO-1 Registrational Study of CRB-701 in Patients with 2L Oropharyngeal Cancer

Corbus Pharmaceuticals announced FDA clearance to initiate its Phase 3 TEMPO-1 study testing CRB-701, a next-generation antibody drug conjugate targeting Nectin-4, in patients with second-line oropharyngeal squamous cell carcinoma (OPSCC). The study aims to evaluate CRB-701's efficacy and safety compared to current therapies, leveraging promising P…

YD Bio Launches Cross-Border Cancer Testing Pilot with Numia Health to Evaluate Expanded Access to Molecular Diagnostics in Canada

YD Bio Launches Cross-Border Cancer Testing Pilot with Numia Health to Evaluate Expanded Access to Molecular Diagnostics in Canada

YD Bio Limited announced a six-month pilot program in collaboration with Numia Health to evaluate a cross-border clinical workflow for physician-ordered, blood-based cancer testing for patients in British Columbia, Canada. The pilot aims to assess the scalability of integrating physician access, mobile blood collection, specimen logistics, and labo…

XFLT Proxy Vote: What Shareholders Need to Know About the Liquidity Plan and Discount Management Programs

XFLT Proxy Vote: What Shareholders Need to Know About the Liquidity Plan and Discount Management Programs

XAI Floating Rate & Alternative Income Trust (XFLT) announces a board-approved liquidity plan involving an initial and two contingent tender offers designed to support shareholder value through a Discount Management Program (DMP). Shareholders are urged to vote for the King Street Capital Management sub-advisory agreement enabling these offers. The…